Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy

NCT02864147 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02864147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02864147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel "Prime and Pull" Strategy
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
November 22, 2022
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dysplasia, cervical intraepithelial neoplasia